Literature DB >> 25601541

Targeting T cell metabolism for therapy.

David O'Sullivan1, Erika L Pearce2.   

Abstract

In the past several years a wealth of evidence has emerged illustrating how metabolism supports many aspects of T cell biology, as well as how metabolic changes drive T cell differentiation and fate. We outline developing principles in the regulation of T cell metabolism, and discuss how these processes are affected in settings of inflammation and cancer. In this context we discuss how metabolic pathways might be manipulated for the treatment of human disease, including how metabolism may be targeted to prevent T cell dysfunction in inhospitable microenvironments, to generate more effective adoptive cellular immunotherapies in cancer, and to direct T cell differentiation and function towards non-pathogenic phenotypes in settings of autoimmunity.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25601541      PMCID: PMC4323623          DOI: 10.1016/j.it.2014.12.004

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  136 in total

1.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

2.  Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Rahul Roychoudhuri; David Clever; Alena Gros; Robert L Eil; Eric Tran; Ken-Ichi Hanada; Zhiya Yu; Douglas C Palmer; Sid P Kerkar; Ryan D Michalek; Trevor Upham; Anthony Leonardi; Nicolas Acquavella; Ena Wang; Francesco M Marincola; Luca Gattinoni; Pawel Muranski; Mark S Sundrud; Christopher A Klebanoff; Steven A Rosenberg; Douglas T Fearon; Nicholas P Restifo
Journal:  Cancer Res       Date:  2014-11-28       Impact factor: 12.701

3.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

4.  Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells.

Authors:  Heather Kopf; Gonzalo M de la Rosa; O M Zack Howard; Xin Chen
Journal:  Int Immunopharmacol       Date:  2007-09-20       Impact factor: 4.932

5.  Anergic T cells are metabolically anergic.

Authors:  Yan Zheng; Greg M Delgoffe; Christian F Meyer; Waipan Chan; Jonathan D Powell
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

6.  An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

Authors:  Dan Rohle; Janeta Popovici-Muller; Nicolaos Palaskas; Sevin Turcan; Christian Grommes; Carl Campos; Jennifer Tsoi; Owen Clark; Barbara Oldrini; Evangelia Komisopoulou; Kaiko Kunii; Alicia Pedraza; Stefanie Schalm; Lee Silverman; Alexandra Miller; Fang Wang; Hua Yang; Yue Chen; Andrew Kernytsky; Marc K Rosenblum; Wei Liu; Scott A Biller; Shinsan M Su; Cameron W Brennan; Timothy A Chan; Thomas G Graeber; Katharine E Yen; Ingo K Mellinghoff
Journal:  Science       Date:  2013-04-04       Impact factor: 47.728

7.  De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.

Authors:  Luciana Berod; Christin Friedrich; Amrita Nandan; Jenny Freitag; Stefanie Hagemann; Kirsten Harmrolfs; Aline Sandouk; Christina Hesse; Carla N Castro; Heike Bähre; Sarah K Tschirner; Nataliya Gorinski; Melanie Gohmert; Christian T Mayer; Jochen Huehn; Evgeni Ponimaskin; Wolf-Rainer Abraham; Rolf Müller; Matthias Lochner; Tim Sparwasser
Journal:  Nat Med       Date:  2014-10-05       Impact factor: 53.440

Review 8.  Mitochondrial pharmacology.

Authors:  Robin A J Smith; Richard C Hartley; Helena M Cochemé; Michael P Murphy
Journal:  Trends Pharmacol Sci       Date:  2012-04-18       Impact factor: 14.819

9.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.

Authors:  David K Finlay; Ella Rosenzweig; Linda V Sinclair; Carmen Feijoo-Carnero; Jens L Hukelmann; Julia Rolf; Andrey A Panteleyev; Klaus Okkenhaug; Doreen A Cantrell
Journal:  J Exp Med       Date:  2012-11-26       Impact factor: 14.307

10.  Activated lymphocytes as a metabolic model for carcinogenesis.

Authors:  Andrew N Macintyre; Jeffrey C Rathmell
Journal:  Cancer Metab       Date:  2013-01-23
View more
  90 in total

1.  Oxidative Stress and Metabolism: The NF-Erythroid 2 p45-Related Factor 2:Kelch-like ECH-Associated Protein 1 System and Regulatory T Lymphocytes in Ischemic AKI.

Authors:  Christopher Y Lu; Natalia de Albuquerque Rocha
Journal:  J Am Soc Nephrol       Date:  2015-08-20       Impact factor: 10.121

Review 2.  T cell metabolic reprogramming and plasticity.

Authors:  Maria Slack; Tingting Wang; Ruoning Wang
Journal:  Mol Immunol       Date:  2015-08-12       Impact factor: 4.407

3.  Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma.

Authors:  Peter J Siska; Kathryn E Beckermann; Frank M Mason; Gabriela Andrejeva; Allison R Greenplate; Adam B Sendor; Yun-Chen J Chiang; Armando L Corona; Lelisa F Gemta; Benjamin G Vincent; Richard C Wang; Bumki Kim; Jiyong Hong; Chiu-Lan Chen; Timothy N Bullock; Jonathan M Irish; W Kimryn Rathmell; Jeffrey C Rathmell
Journal:  JCI Insight       Date:  2017-06-15

Review 4.  Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.

Authors:  Kurt R Stenmark; Rubin M Tuder; Karim C El Kasmi
Journal:  J Appl Physiol (1985)       Date:  2015-04-30

5.  Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-α-Dependent Intensification of Oxidative Stress and Tumor Cell Death.

Authors:  Tsadik Habtetsion; Zhi-Chun Ding; Wenhu Pi; Tao Li; Chunwan Lu; Tingting Chen; Caixia Xi; Helena Spartz; Kebin Liu; Zhonglin Hao; Nahid Mivechi; Yuqing Huo; Bruce R Blazar; David H Munn; Gang Zhou
Journal:  Cell Metab       Date:  2018-06-07       Impact factor: 27.287

Review 6.  Metabolic regulation of pathogenic autoimmunity: therapeutic targeting.

Authors:  Xiangyu Teng; Caleb Cornaby; Wei Li; Laurence Morel
Journal:  Curr Opin Immunol       Date:  2019-08-15       Impact factor: 7.486

7.  Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis.

Authors:  Luigi Franchi; Ivan Monteleone; Ling-Yang Hao; Mark A Spahr; Wenpu Zhao; Xikui Liu; Kellie Demock; Aditi Kulkarni; Chuck A Lesch; Brian Sanchez; Laura Carter; Irene Marafini; Xiao Hu; Oksana Mashadova; Min Yuan; John M Asara; Harinder Singh; Costas A Lyssiotis; Giovanni Monteleone; Anthony W Opipari; Gary D Glick
Journal:  J Immunol       Date:  2017-02-27       Impact factor: 5.422

Review 8.  An update on lupus animal models.

Authors:  Wei Li; Anton A Titov; Laurence Morel
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006

Review 9.  Immune Cell Metabolism in Systemic Lupus Erythematosus.

Authors:  Seung-Chul Choi; Anton A Titov; Ramya Sivakumar; Wei Li; Laurence Morel
Journal:  Curr Rheumatol Rep       Date:  2016-11       Impact factor: 4.592

Review 10.  Immunometabolism and autoimmunity.

Authors:  Jenny Freitag; Luciana Berod; Thomas Kamradt; Tim Sparwasser
Journal:  Immunol Cell Biol       Date:  2016-08-26       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.